CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics

COVID-19, the human coronavirus disease caused by SARS-CoV-2, was reported for the first time in Wuhan, China in late 2019. COVID-19 has no preventive vaccine or proven standard pharmacological treatment, and consequently, the outbreak swiftly became a pandemic affecting more than 215 countries arou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Infect Microbiol
Main Authors: Kumar, Prashant, Malik, Yashpal Singh, Ganesh, Balasubramanian, Rahangdale, Somnath, Saurabh, Sharad, Natesan, Senthilkumar, Srivastava, Ashish, Sharun, Khan, Yatoo, Mohd. Iqbal, Tiwari, Ruchi, Singh, Raj Kumar, Dhama, Kuldeep
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Cellular and Infection Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7673385/
https://ncbi.nlm.nih.gov/pubmed/33251158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2020.576875
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados